| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/24/2011 | WO2010003319A8 Hydrates of erythromycin salts, the preparation and the use thereof |
| 02/24/2011 | WO2009153434A8 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity on the inflammatory response |
| 02/24/2011 | US20110046982 Methods and compositions related to viral inhibition |
| 02/24/2011 | US20110046606 Catheter injectable depot compositions and uses thereof |
| 02/24/2011 | US20110046233 Gossypol derivatives, production method thereof and uses of same |
| 02/24/2011 | US20110046209 RNA-Induced Translational Silencing and Cellular Apoptosis |
| 02/24/2011 | US20110046208 Nucleolar targeting of therapeutics against hiv |
| 02/24/2011 | US20110046199 Small molecule inhibitors of hiv proteases |
| 02/24/2011 | US20110046195 Non-Lactone Carbocyclic and Heterocyclic Antagonists and Agonists of Bacterial Quorum Sensing |
| 02/24/2011 | US20110046161 Hcv ns3 protease inhibitors |
| 02/24/2011 | US20110046155 Hydrobenzamide derivatives as inhibitors of hsp90 |
| 02/24/2011 | US20110046142 Antibiotic compounds |
| 02/24/2011 | US20110046125 Method for treating infections |
| 02/24/2011 | US20110046113 Amine compound and use thereof |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046107 Sulfonyl-substituted carbapenem compounds |
| 02/24/2011 | US20110046102 Azabicyclic compounds, preparation thereof and use of same as drugs, especially beta-lactamase inhibitors |
| 02/24/2011 | US20110046101 Bate-lactamase inhibitors |
| 02/24/2011 | US20110046091 Composition and methods used during anti-hiv treatment |
| 02/24/2011 | US20110046059 Pharmaceutically acceptable formulations/compositions for peptidyl drugs |
| 02/24/2011 | US20110046043 Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices |
| 02/24/2011 | US20110046042 Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof |
| 02/24/2011 | US20110046041 Methods of inhibiting and treating biofilms using glycopeptide antibiotics |
| 02/24/2011 | US20110046039 Post-exposure prophylaxis and treatment of infections |
| 02/24/2011 | US20110045110 Nutritional Compositions Containing Punicalagins |
| 02/24/2011 | US20110045107 Dietary Supplement and Method for the Treatment of Digestive Tract Ulcers in Equines |
| 02/24/2011 | US20110045082 Agglomerates by crystallisation |
| 02/24/2011 | US20110045079 Dry powders of cellular material |
| 02/24/2011 | US20110045076 Linear order release polymer |
| 02/24/2011 | US20110045073 Methods and compositions of sphingolipid for preventing and treating microbial infections |
| 02/24/2011 | US20110045070 Combination therapy |
| 02/24/2011 | US20110045059 Vaccine against varicella zoster virus |
| 02/24/2011 | US20110045057 Virosomes Comprising Hemagglutinin Derived from an Influenza Virus Produced in a Cell Line, Compositions, Methods of Manufacturing, Use Thereof |
| 02/24/2011 | US20110045049 Immunomodulating compositions and methods of use |
| 02/24/2011 | US20110045029 Oral formulation for delivery of poorly absorbed drugs |
| 02/24/2011 | US20110045025 Pharmaceutical Compositions Containing Clostridium Difficile Toxoids A and B |
| 02/24/2011 | US20110045023 Recombinant RSV Virus Expression Systems And Vaccines |
| 02/24/2011 | US20110045022 Vaccines including antigen from four strains of influenza virus |
| 02/24/2011 | US20110045021 Sugar immunogens |
| 02/24/2011 | US20110045020 Nucleic acid comprising chimeric gene derived from hepatitis c virus |
| 02/24/2011 | US20110045018 Astrovirus species |
| 02/24/2011 | US20110045012 Anti-atheroma vaccine |
| 02/24/2011 | US20110045011 TRUNCATED RECOMBINANT MAJOR OUTER MEMBRANE PROTEIN ANTIGEN (R56) OF ORIENTIA TSUTSUGAMUSHI STRAINS KARP, KATO and GILLIAM AND ITS USE IN ANTIBODY BASED DETECTION ASSAYS AND VACCINES |
| 02/24/2011 | US20110045007 Fusion or linked proteins with extended half life |
| 02/24/2011 | US20110045001 Transfection results of non-viral gene delivery systems by influencing of the innate immune system |
| 02/24/2011 | US20110044995 Anti-hiv monoclonal antibody |
| 02/24/2011 | US20110044994 Human immunodeficiency virus (hiv)-neutralizing antibodies |
| 02/24/2011 | US20110044976 Humanized antibodies |
| 02/24/2011 | US20110044975 Treatment of prion protein related diseases |
| 02/24/2011 | US20110044974 Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy |
| 02/24/2011 | US20110044968 Compositions for treatment with metallopeptidases, methods of making and using the same |
| 02/24/2011 | US20110044966 Use of a substance for manufacturing of a medicament for treatment of common cold |
| 02/24/2011 | US20110044946 Genetec regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 02/24/2011 | US20110044943 Anti-Viral Compounds, Compositions, And Methods Of Use |
| 02/24/2011 | US20110044941 Immunotherapy for reversing immune suppression |
| 02/24/2011 | US20110044918 Novel sulfamide derivatives and cosmetic use thereof |
| 02/24/2011 | US20110044917 Dental composition for treating peri-implantitis |
| 02/24/2011 | US20110044915 Confectionery containing algae for the prevention of oro-dental infections |
| 02/24/2011 | US20110044901 Novel compounds |
| 02/24/2011 | US20110044898 Translocator protein ligands |
| 02/24/2011 | US20110044897 Method of imaging localized infections |
| 02/24/2011 | DE10251709C5 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3 |
| 02/24/2011 | DE102009038123A1 Substituierte (Thiazolyl-carbonyl)imidazolidinone und ihre Verwendung Substituted (thiazolyl-carbonyl) imidazolidinones and their use |
| 02/24/2011 | CA2772242A1 Broad spectrum preservation blends |
| 02/24/2011 | CA2771609A1 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | CA2771484A1 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | CA2771453A1 Substituted (thiazolyl-carbonyl)imidazolidinones and use thereof |
| 02/24/2011 | CA2771325A1 Antibacterial food composition |
| 02/24/2011 | CA2769407A1 Mimotopes of hiv and uses thereof |
| 02/23/2011 | EP2287316A1 Antigenic polypeptides |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287300A1 Bacterial toxin vaccine |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287191A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287190A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287173A1 10a-azalide compound having 4-membered ring structure |
| 02/23/2011 | EP2287167A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 02/23/2011 | EP2287150A2 Substituted tetracycline compounds |
| 02/23/2011 | EP2287148A2 Substituted tetracycline compounds |
| 02/23/2011 | EP2287140A2 Substituted tetracycline compounds |
| 02/23/2011 | EP2286836A1 Immunostimulating agent |
| 02/23/2011 | EP2286831A1 A method of inducing a CTL response |
| 02/23/2011 | EP2286823A2 Use of Cistus incanus extracts for the preparation of a medicament for the prevention and/or treatment of influenza |
| 02/23/2011 | EP2286812A1 Solubilized topoisomerase poisons |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2286800A1 Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs |
| 02/23/2011 | EP2285962A2 Novel therapeutic agents against hepatitis |
| 02/23/2011 | EP2285833A1 AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME |
| 02/23/2011 | EP2285807A1 Heterocyclic antiviral compounds |
| 02/23/2011 | EP2285802A1 Oxo-imidazolyl compounds having antibacterial activity |
| 02/23/2011 | EP2285405A2 Vaccine compositions and methods |
| 02/23/2011 | EP2285393A1 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndroms |
| 02/23/2011 | EP2285390A1 Method for obtaining an extract of cranberry marc that can be used in particular in the prevention and treatment of conditions such as caries, gingivitis or sore throats |
| 02/23/2011 | EP2285244A1 Sialic acid to support the immune system in the elderly |
| 02/23/2011 | EP2046378B9 Use of bacterial polysaccharides for biofilm inhibition |
| 02/23/2011 | EP1924272B1 Use of cistus incanus extracts for the preparation of a medicament for the prevention and/or treatment of influenza |
| 02/23/2011 | EP1901723B1 Antimicrobial materials |
| 02/23/2011 | EP1801209B1 Modified human hepatitis c virus genomic rna having autonomous replicative competence |
| 02/23/2011 | EP1740599B1 Anthracycline derivatives |